XML 40 R22.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Commitments and Contingencies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract] |
Patent And Technology License Agreement, Milestone Payments [Table Text Block] | Pursuant to an amendment on October 19, 2015, the Company will pay milestone payments as follows:
Phase |  | Amount |
Commencement of Phase II Study for a licensed product |  | $ | 200,000 |
Commencement of Phase III Study for a licensed product |  | $ | 250,000 |
Filing of a New Drug Application for a licensed product |  | $ | 400,000 |
Receipt of market approval for a licensed product |  | $ | 500,000 |

X
- Definition Tabular disclosure of milestone payments under patent and technology license agreement. + References No definition available. + Details
Name: | mbrx_PatentAndTechnologyLicenseAgreementMilestonePaymentsTableTextBlock
Namespace Prefix: | mbrx_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration